Sigma Pharmaceuticals Ltd
(ASX:SIP) has appointed Mark Hooper as its new managing director and CEO.
Mr Hooper joint Sigma from PaperlinX where he was chief financial officer since 2008, previous to this he was the chief financial officer of Sigma from 2001 through to 2006.
During 2006 to 2008 Mr Hooper was CFO at Symbion Health, and chief operating officer for the consumer and pharmacy divisions.
Chairman Dr John Stocker says the news is excellent for Sigma, saying the company has recruited a CEO who will hit the ground running, with a deep knowledge of the company and the industry.
Mr Stocker says Mr Hooper will be a critical element in the company’s next phase of development in conjunction with the board headed by new chairman Brian Jamieson, who takes over at the forthcoming annual general meeting.
Mr Hooper is expected to start with Sigma in September 2010. Sigma posted a $389 million loss for the 12 months to January 30, 2010.
